Methotrexate
Who holds supplier records for Methotrexate? 9 organisations hold a current record for Methotrexate: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), China (2), Germany (1) and Finland (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Methotrexate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/methotrexate
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Methotrexate expires 28 Oct 2035. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Methotrexate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CF PHARMA LTDCEPActive DMF 25957 · latest filing Apr 2012
- EXCELLA GMBH AND CO KGGermanyCEP Company GMP cert on recordActive DMF 11704 · latest filing Oct 1995
- FERMION OYFinlandCEP Company GMP cert on recordActive DMF 4246 · latest filing Aug 1981
- Huzhou Zhanwang Pharmaceutical Co.,ltd.ChinaCEPActive DMF 20255 · latest filing Jan 2007
- RAVI BIOLIFE PRIVATE LTDIndiaCEPActive DMF 39997 · latest filing May 2024
- SHILPA PHARMA LIFESCIENCES LTDIndiaCEPActive DMF 42056 · latest filing Jun 2025
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 43433 · latest filing Jan 2026
- SICHUAN ELIXIR PHARMACEUTICAL CO LTDActive DMF 39758 · latest filing Mar 2024
- Sichuan Huiyu Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 43530 · latest filing Apr 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Methotrexate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| EXCELLA GMBH & CO. KG Feucht | DE | CEP 2022-373 - Rev 01 Methotrexate, Base | Jul 2026 | Inspected Apr 2026 Germany |
| SHILPA PHARMA LIFESCIENCES LIMITED Raichur | IN | CEP 2024-465 - Rev 00 Methotrexate | Mar 2026 | — |
| RAVI BIOLIFE PRIVATE LTD. Mumbai | IN | CEP 2024-257 - Rev 00 Methotrexate | Jun 2025 | — |
| FERMION OY Espoo | FI | CEP 2001-145 - Rev 05 Methotrexate | Jan 2025 | Inspected Feb 2026 Finland |
| HUZHOU ZHANWANG PHARMACEUTICAL CO., LTD. Linghu Town | CN | R1-CEP 2006-271 - Rev 01 Methotrexate | Feb 2021 | — |
| CF PHARMA LTD. Budapest | HU | R1-CEP 2008-238 - Rev 02 Methotrexate | Feb 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (10)
Organisations whose Type II DMFs for Methotrexate are no longer active. These show a past filing, not current supply.
Show all 10 historical records
- China · Inactive DMF 38314 · filed Apr 2023
- BENZOCHEM LIFESCIENCES PVT LTDInactive DMF 21270 · filed Jan 2008
- China · Inactive DMF 21118 · filed Nov 2007
- LIANYUNGANG PHARMACEUTICAL FACTORYInactive DMF 12833 · filed Jan 1998
- SUMIKA FINE CHEMICALS CO LTDInactive DMF 8185 · filed Aug 1989
- SIGMA F AND D DIV LTDInactive DMF 7293 · filed Dec 1987
- BEN VENUE LABORATORIES INCInactive DMF 6122 · filed Dec 1985
- PFIZER LTDInactive DMF 4018 · filed Nov 1980
- PFANSTIEHL LABORATORIES INCInactive DMF 3189 · filed Apr 1978
- MONSANTO COInactive DMF 3047 · filed Nov 1977
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (50 listed products contain Methotrexate). The latest listed patent expires 28 Oct 2035. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Methotrexate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL34259).
Chemical identity
- IUPAC name
- (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
- Canonical SMILES
- CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
- InChIKey
- FBOZXECLQNJBKD-ZDUSSCGKSA-N
- Synonyms
- ADX-2191, Amethopterin, CL 14377, CL-14377, D-amethopterin, D-methotrexate, Ebetrex, EMT-25299, Emtexate high-pot, Emtexate pf, Jylamvo, Maxtrex
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Folate Analog Metabolic Inhibitor
- Mechanism of action
- Folic Acid Metabolism Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Methotrexate?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Methotrexate: CF PHARMA LTD, EXCELLA GMBH AND CO KG (Germany), FERMION OY (Finland), Huzhou Zhanwang Pharmaceutical Co.,ltd. (China), RAVI BIOLIFE PRIVATE LTD (India), SHILPA PHARMA LIFESCIENCES LTD (India), MSN Laboratories Private Limited (India) and SICHUAN ELIXIR PHARMACEUTICAL CO LTD, and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Methotrexate Drug Master Files are active?
CF PHARMA LTD (DMF 25957), EXCELLA GMBH AND CO KG (DMF 11704), FERMION OY (DMF 4246), Huzhou Zhanwang Pharmaceutical Co.,ltd. (DMF 20255), RAVI BIOLIFE PRIVATE LTD (DMF 39997), SHILPA PHARMA LIFESCIENCES LTD (DMF 42056), MSN Laboratories Private Limited (DMF 43433) and SICHUAN ELIXIR PHARMACEUTICAL CO LTD (DMF 39758) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Methotrexate records mean?
10 organisations have only inactive Type II DMFs for Methotrexate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Methotrexate have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Methotrexate on the EDQM register, including EXCELLA GMBH & CO. KG Feucht (DE), SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN), RAVI BIOLIFE PRIVATE LTD. Mumbai (IN), FERMION OY Espoo (FI), HUZHOU ZHANWANG PHARMACEUTICAL CO., LTD. Linghu Town (CN) and CF PHARMA LTD. Budapest (HU). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Methotrexate?
Yes. The latest patent listed for an approved US product containing Methotrexate expires 28 Oct 2035, across 50 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Methotrexate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Methotrexate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.